Neuromuscular electrical stimulation for cancer pain in children with osteosarcoma: A protocol of systematic review

Tian-Shu Wang1, Shou-Feng Wang2, Wei-Dong Song3

  • 1Second Ward of Orthopedis Department.

Medicine
|August 15, 2020
PubMed

Insights

This systematic review examines if neuromuscular electrical stimulation (NMES) effectively and safely manages cancer pain (CP) in children with osteosarcoma. Findings will guide treatment decisions for pediatric osteosarcoma pain.

Area of Science:

  • Oncology
  • Pain Management
  • Rehabilitation

Background:

  • Osteosarcoma is a primary bone cancer in children, often associated with significant cancer pain (CP).
  • Current pain management strategies for pediatric osteosarcoma require comprehensive evaluation.
  • Neuromuscular electrical stimulation (NMES) is a potential non-pharmacological intervention for pain relief.

Purpose of the Study:

  • To systematically review the effectiveness of NMES in managing cancer pain (CP) in pediatric osteosarcoma patients.
  • To assess the safety profile of NMES when used for CP in this population.
  • To synthesize existing evidence to inform clinical practice.

Main Methods:

  • A systematic review protocol was established, searching multiple electronic databases (Cochrane Library, MEDLINE, EMBASE, Web of Science, Scopus, CNKI, VIP).
  • Eligibility criteria were applied through a three-stage screening of titles, abstracts, and full-text studies.
  • Study quality was assessed using the Cochrane Risk of Bias Tool, with plans for narrative synthesis and meta-analysis.

Main Results:

  • This review will synthesize findings from high-quality trials evaluating NMES for cancer pain (CP) in pediatric osteosarcoma.
  • The effectiveness and safety data from included studies will be critically appraised.
  • Results will provide a comprehensive overview of NMES's role in managing this specific patient group.

Conclusions:

  • The study aims to determine the efficacy and safety of NMES for cancer pain (CP) in children with osteosarcoma.
  • Evidence generated will support or refute the use of NMES as a viable treatment option.
  • Findings will contribute to evidence-based guidelines for pediatric oncology pain management.
Abstract

Related Concept Videos